Several studies have implicated FOXM1 to play a major role in chemo-resistance in gastric cancer49,50, glioblastoma51, non-small-cell lung cancer52 and most recently, also in oral cancer where it is proven to predict poor patient survival53. This evidence concerns the gene FOXM1 and lip and oral cavity carcinoma.